The screening—known as a liquid biopsy—is being rolled out to around 15,000 patients with suspected lung cancer, NHS England has announced. There are also plans to expand it to advanced breast ...

The fast-track system is a valuable opportunity that will guarantee future collaboration between innovators in the sector and the NHS. It could also represent the first step to a more efficient ...

The clinical trial (NCT04079166) is part of the NHS Cancer Vaccine Launch Pad (CVLP), a framework launched in May 2024 to help fast-track eligible patients into studies at nearby hospitals ...

Skin cancer patients are set to be fast-tracked into a clinical trial for a new cancer vaccine, NHS England has announced. The vaccine, called iSCIB1+, is designed to help the immune system better ...

NICE and NHS England have unveiled very significant plans to change how new medicines are reviewed, including a fast track for the most cost-effective drugs – but also a built in affordability test.

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...

New data reveals the stark differences in NHS funding for continuing healthcare (CHC) across England’s 42 integrated care ...

According to NHS Shared Business Services (NHS SBS), this framework launch complements the commitments made at the 2025 ...

A new wave of modular construction is set to transform the UK's public infrastructure, with NHS Shared Business Services (NHS ...

Thousands of cancer patients are set to benefit from a world-first NHS blood test that speeds up access to treatment and avoids the need for invasive biopsies.. The screening—known as a liquid ...

Patients with an advanced type of skin melanoma in England will be given expedited access to a new vaccine being developed by Scancell as part of a National Health Service (NHS) clinical trial. UK ...